
The cPLA2α inhibitor efipladib decreases nociceptive responses without affecting PGE2 levels in the cerebral spinal fluid
Keywords: پاسخ ناسازگار; Nociceptive response; PGE2; cPLA2; Efipladib; Inflammation; CSF